Show simple item record

Authordc.contributor.authorLi, Yiran E.
Authordc.contributor.authorSowers, James R.
Authordc.contributor.authorHetz Flores, Claudio Andrés
Authordc.contributor.authorRen, Jun
Admission datedc.date.accessioned2023-09-28T17:33:54Z
Available datedc.date.available2023-09-28T17:33:54Z
Publication datedc.date.issued2022
Cita de ítemdc.identifier.citationCell Death and Disease (2022) 13:504es_ES
Identifierdc.identifier.other10.1038/s41419-022-04942-2
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/195874
Abstractdc.description.abstractThe endoplasmic reticulum (ER) and mitochondria are interconnected intracellular organelles with vital roles in the regulation of cell signaling and function. While the ER participates in a number of biological processes including lipid biosynthesis, Ca2+ storage and protein folding and processing, mitochondria are highly dynamic organelles governing ATP synthesis, free radical production, innate immunity and apoptosis. Interplay between the ER and mitochondria plays a crucial role in regulating energy metabolism and cell fate control under stress. The mitochondria-associated membranes (MAMs) denote physical contact sites between ER and mitochondria that mediate bidirectional communications between the two organelles. Although Ca2+ transport from ER to mitochondria is vital for mitochondrial homeostasis and energy metabolism, unrestrained Ca2+ transfer may result in mitochondrial Ca2+ overload, mitochondrial damage and cell death. Here we summarize the roles of MAMs in cell physiology and its impact in pathological conditions with a focus on cardiovascular disease. The possibility of manipulating ER-mitochondria contacts as potential therapeutic approaches is also discussed.es_ES
Patrocinadordc.description.sponsorshipNational Key R&D Program of China 2017YFA0506000 United States Department of Defense Air Force Office of Scientific Research (AFOSR) FA9550-16-1-0384 Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDAP 15150012 Takeda Pharmaceutical Company Ltd P09-015-F United States Department of Defense W81XWH2110960es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherNaturees_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceCell Death and Diseasees_ES
Keywordsdc.subjectMitochondria-associated membraneses_ES
Keywordsdc.subjectEndoplasmic-reticulum stresses_ES
Keywordsdc.subjectSigma-1 receptores_ES
Keywordsdc.subjectCyclophilin-Des_ES
Keywordsdc.subjectMitofusin 2es_ES
Keywordsdc.subjectERes_ES
Keywordsdc.subjectCalciumes_ES
Keywordsdc.subjectCA2+es_ES
Keywordsdc.subjectApoptosises_ES
Keywordsdc.subjectDynamicses_ES
Títulodc.titleCell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseaseses_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorapces_ES
Indexationuchile.indexArtículo de publícación WoSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States